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Abstract
Background: Although several genes and proteins have been implicated in the development of
melanomas, the molecular mechanisms involved in the development of these tumors are not well
understood. To gain a better understanding of the relationship between the cell growth,
tumorigenesis and differentiation, we have studied a highly malignant cat melanoma cell line that
trans-differentiates into neuronal cells after exposure to a feline endogenous retrovirus RD114.
Methods: To define the repertoire of proteins responsible for the phenotypic differences between
melanoma and its counterpart trans-differentiated neuronal cells we have applied proteomics
technology and compared protein profiles of the two cell types and identified differentially
expressed proteins by 2D-gel electrophoresis, image analyses and mass spectrometry.
Results: The melanoma and trans-differentiated neuronal cells could be distinguished by the
presence of distinct sets of proteins in each. Although approximately 60–70% of the expressed
proteins were shared between the two cell types, twelve proteins were induced de novo after
infection of melanoma cells with RD114 virus in vitro. Expression of these proteins in trans-
differentiated cells was significantly associated with concomitant down regulation of growth
promoting proteins and up-regulation of neurogenic proteins (p = < 0.001). Based on their
physiologic properties, >95% proteins expressed in trans-differentiated cells could be associated
with the development, differentiation and regulation of nervous system cells.
Conclusion: Our results indicate that the cat melanoma cells have the ability to differentiate into
distinct neuronal cell types and they express proteins that are essential for self-renewal. Since
melanocytes arise from the neural crest of the embryo, we conclude that this melanoma arose from
embryonic precursor stem cells. This model system provides a unique opportunity to identify
domains of interactions between the expressed proteins that halt the tumorigenic potential of
melanoma cells and drive them toward neurogenerative pathways involved in early neurogenesis.
A better understanding of these proteins in a well-coordinated signaling network would also help
in developing novel approaches for suppression of highly malignant tumors that arise from stem-
like embryonic cells.
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Background
Melanomas are a heterogeneous group of tumors that
arise in the skin, eye, meninges and other parts of the
body. While early stages of cutaneous melanomas are rec-
ognized by changes in the size, shape or color of black
nevi, most cancer cells grow downward from the skin and
invade neighboring tissues before they are detected as
highly metastatic tumors in lymph nodes or other organs
[1]. Patients with malignant melanomas do not respond
well to the currently available therapies and most treat-
ments remain ineffective.
To gain a better understanding of mechanisms involved in
the growth, differentiation and transformation of cells, we
have studied a fully differentiated (pigmented) highly
malignant cat melanoma cell line CT1413, that trans-dif-
ferentiates into neuronal cells, 48–72 hours after infection
with the endogenous cat retrovirus RD114 in vitro [2,3].
The trans-differentiated cells exhibit long multipolar cyto-
plasmic extensions that form a network of connections
with giant multinucleated neuronal cells and smaller
glial-like cells (Fig. 1A, B &1C). This transformation is a
highly specific event for CT1413 cells and its interaction
with RD114 virus since no morphological change occurs
when these cells are treated with various chemicals known
to induce cell differentiation (dexamethasone, insulin,
isobutyl-methyl-xathine) or they are infected separately
with primate retroviruses that use the same neutral amino
acid (NAA) transporter proteins as receptors as does
RD114 virus [4,3]. In addition, human, mouse and ham-
ster melanoma cell lines infected with RD114 virus, or
CT1413 cells infected with the feline or murine leukemia
viruses also fail to exhibit any change in cellular
morphology.
Since RD114 virus does not replicate in the terminally
trans-differentiated neuronal cells, we hypothesized that
binding of virus to its receptor on the melanoma cell
membrane could induce conformational changes that
generate a cascade of molecular interactions through dis-
tinct signals which arrest the tumor cell growth and drive
them toward neurogenetic pathways. To test this hypoth-
esis we have analyzed comprehensive protein profiles of
both the malignant melanoma and its counterpart trans-
differentiated neuronal cells by 2-dimensional gel electro-
phoresis (2DGE) and identified differentially expressed
proteins in the two cell types by Matrix-Assisted-Laser-
Desorption-Ionization-Time-Of-Flight mass spectrometry
(MALDI-TOF-MS). Herein we show that the trans-differ-
entiation of melanoma into neuronal cells is directly asso-
ciated with de novo expression of pro-inflammatory
cytokines, neuro-regulatory enzymes/kinases, neuro-
trophic factors and concomitant suppression of growth-
Photographs of the cat melanoma cell cultures before and  after trans-differentiation Figure 1
Photographs of the cat melanoma cell cultures 
before and after trans-differentiation. A: Uninfected 
control melanoma cells 48 hours after culture. B & C: Two 
different cultures of trans-differentiated neuronal cells, 48–72 
hours after infection with the endogenous feline retrovirus 
RD114.
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promoting proteins. This repertoire of proteins is not only
responsible for the generation of neuronal cells but it is
also involved in the reversion of a highly malignant tumor
into non-cancerous neuronal cells.
Results and Discussion
We have compared 3129 protein spots in 15 gels derived
from RD114-infected and uninfected melanoma cells
from two independent experiments and analyzed peptide
fingerprints of 467 differentially expressed (up-regulated
and downregulated) protein spots by MALDI-TOF-MS. A
total of 46 proteins were confirmed unambiguously from
302 spots excised from multiple gels of both experiments
(Figure 2). The remaining 165 spots did not identify any
protein from the SWISS-PROT database or proteins were
not identified reproducibly from corresponding spots in
different gels. Since species-specific isomers and protein-
protein interactions in cat cells may be functionally differ-
ent from those of human or other species, all 46 proteins
reported here were confirmed from the feline protein
database.
By mass spectrometry each gel spot contained either a sin-
gle protein per spot in a non-complexed form or as a com-
plex of 2–8 proteins in one spot. The frequency of
distribution for the 46 proteins among the 302 spots
included 82 single protein spots (32 in melanoma and 50
in neuronal cells) and 220 spots containing protein com-
plexes (103 in melanoma and 117 in neuronal cells.
Among the differentially identified proteins, 12 were
expressed de novo exclusively in neuronal cells, two were
detected only in melanoma cells and 32 of 46 (>69%)
proteins were shared between the two cell types (Table 1,
2, 3 and Fig 2). Three of the 12 de novo expressed proteins
in neuronal cells were detected in single, non-complexed
form (designated by * in Table 1 and Fig. 2A) and 9 pro-
teins were detected in complexes with other proteins (Fig.
2A). All newly synthesized or upregulated proteins
belonged to families of cytokines, neuro-regulatory
enzymes/ kinases, sensory, and other signaling proteins
(Tables 1, 2, 3). The two proteins that were expressed only
in melanoma but not in any of the gels derived from neu-
ronal cells were cyclin dependent kinase inhibitor 1 (P21-
CDNA**) expressed in a non complexed /single form and
matrilysin or matrix metalloproteinase-7 (MMO7) (Fig.
2B; Table 1B). These proteins have been shown to be crit-
ical for maintaining cell growth and metastasis respec-
46 proteins identified by MALDI-TOF-MS from multiple gels derived both from melanoma and neuronal cells Figure 2
46 proteins identified by MALDI-TOF-MS from multiple gels derived both from melanoma and neuronal cells. X-axis = Protein 
names (abbreviations): Y-axis = frequency or # of times a protein is detected and confirmed by mass spectrometry from mul-
tiple gels. Pink bars represent proteins in neuronal cells and Blue bars indicate proteins present in melanoma cells. Protein 
names, abbreviations and accession numbers are from SWISS-PROT database used for protein identification (See Table 1-3 for 
details). One asterisk (*) indicates that the protein is detected in single, non-complexed form only in neuronal cells and two 
asterisks (**) indicate that this protein is detected as single protein only in melanoma cells. A: From left to right, expression of 
12 proteins detected exclusively in trans-differentiated neuronal cells; 3 proteins were detected in single (non-complexed) 
form only and are marked by (*) and 9 proteins were expressed as complexes with other proteins. B: Two proteins were 
detected in melanoma cells only (i.e. NOT detected in neuronal cells); CDNA was expressed as a single protein (**) and 
MMO7 was present in a complex form. C: Expression frequencies of 32 proteins expressed both in melanoma and neuronal 
cells. Left side of the graph displays proteins that are detected at higher frequency in melanoma and the right side shows pro-
teins that are detected at a higher frequency in trans-differentiated neuronal cells.
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Table 1: Proteins Expressed Exclusively in Neuronal Cells
Protein Name Abbreviation Accession # Functional Category
Acetylcholinesterase precursor ACES O62763 Membrane Enzyme
Beta-2 adrenergic receptor B2AR Q9TST5 Membrane Receptor
Beta-hexosaminidase beta chain precursor HEXB P49614 Lysosomal Enzyme
Interleukin-1 receptor beta precursor IL1B P41687 Cytokine Receptor
Interleukin-2 receptor alpha chain precursor IL2A* P41690 Cytokine Receptor
Interleukin-6 precursor IL6* P41683 Cytokine
Interferon gamma precursor ING P46402 Cytokine
Macrophage colony stimulating factor I receptor precursor KFMS P13369 Membrane tyrosine kinase Receptor
Major allergen I polypeptide chain 2 precursor FEL2 P30440 Cytoplasmic Cat Allergen
Lipoprotein lipase precursor LIPL P55031 Membrane Enzyme
Red-sensitve opsin OPSR O18913 Sensory Retinal protein
Proto-oncogene serine/threonine-protein kinase pim-1 PIM1* Q95LJ0 Serine Threonine Kinase
B:
Proteins Expressed Exclusively in Melanoma cells
Protein Name Abbreviation Accession # Functional Category
Cyclin-dependent kinase inhibitor 1 CDNA** O19002 Nuclear Cell Cycle Protein
Matrilysin precursor MMO7 P55032 Membrane Enzyme
A: shows 12 proteins that were expressed exclusively in neuronal cells (ACES, B2AB, FEL-2, HEXB, IL1B, IL2A*, IL6*, ING, KFMS, LIPL, CPSR and 
PIM1). One asterisk (*) indicates that the protein is detected in single, non-complexed form in neuronal cells only. B: lists two proteins (CDNA** 
and MMO7) that were expressed exclusively in melanoma (i.e. not detected in trans-differentiated neuronal cells. Two asterisks (**) indicate that 
the protein is detected in single, non-complexed form in melanoma cells only.
Table 2: Higher Detection Frequency in Neuronal Cells
Protein Name Abbreviation Accession # Functional Category
Alkaline Phosphatase PPBT Q29486 Membrane Phosphatase
Aminopeptidase N AMPN P79171 Membrane Enzyme
Arylsulfatase B precursor ARSB P33727 Lysosomal Enzyme
Brain-derived neurotrophic factor precursor BDNF* Q9TST3 Neurotrophic Factor
Cellular tumor suppressor p53 P53* P41685 Nuclear
Dipeptidyl peptidase IV DPP4 Q9N2I7 Membrane Enzyme
Glutamate decarboxylase, 67 kDa isoform DCEI P14748 Cytoplasmic Enzyme
Integrin beta-1 precursor ITB1 P53713 Membrane Receptor
Interleukin-1 beta convertase precursor ICE1 Q9MZV6 Cytoplasmic Enzyme
Lysosomal alpha-mannosidase precursor M2B1 O46432 Lysosomal Enzyme
Major prion protein precursor PRIO O18754 Membrane Prion Protein
Mast/stem cell growth factor receptor precursor KIT Q28889 Membrane Tyrosine Kinase Receptor
NADH-Ubiquinone oxidoreductase chain 5 NU5M P48921 Mitochondrial Enzyme
Polycomb complex protein BMI-1 BMI1 Q9TST0 Nuclear Protein
Pyruvate kinase, M1 isozyme KPYM P11979 Pyruvate Kinase
Serum albumin precursor*** ALBU* P49064 Cytoplasmic Albumin Protein
Sodium/calcium exchanger 1 precursor NAC1 P48767 Membrane Calcium Ion Channel (Plasma Membrane)
T-cell surface glycoprotein CD8 beta chain precursor CD8B P79336 Membrane Receptor
Toll-like receptor 4 precursor TLR4 P58727 Membrane Receptor
Transferrin receptor protein 1 TFR1 Q9MYZ3 Membrane Receptor
Zona pellucida sperm-binding protein 2 precursor ZP2* P47984 Membrane Receptor
Zona pellucida sperm-binding protein B precursor ZP4 P48834 Membrane Receptor
Proteins with higher frequency of detection in complex forms in neuronal cells compared to melanoma. Ten proteins were detected in single as well 
as in complex forms in both melanoma and neuronal cells. These proteins displayed a higher frequency of detection in neuronal cells than in 
melanoma. Four proteins Fel d 2 /ALBU*, BDNF*, tumor suppressor protein (P53*) and zona pellucida-2 (ZP2*) were detected both in single (*) 
and complex forms only in neuronal cells. These proteins were present only in complexes in melanoma cells. The ALBU and P53* proteins also 
showed increased frequency of detection in the neuronal cells than in melanoma (also see Fig 2C*) and BDNF and ZP2 showed similar detection 
frequencies in the two cell types.Journal of Translational Medicine 2005, 3:14 http://www.translational-medicine.com/content/3/1/14
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tively [5,6]. The binomial probability for the distribution
of the 12 newly expressed proteins in the trans-differenti-
ated cells compared to melanoma was statistically signifi-
cant (Fisher's exact test p = 0.007).
Tables 2 and 3 show proteins that are expressed both in
melanoma and neuronal cells. Of the 32 shared proteins
in melanoma and trans-differentiated neuronal cells, 10
were detected in single as well as in complex forms, 21
proteins were present in complex forms and one protein,
the T-cell surface glycoprotein CD8 beta chain (CD8B)
was detected in a single form in both cell types but the
complex form of this protein was present only in the neu-
ronal cells (Tables 2 &3 ; Fig. 2C). Each of the 32 proteins
derived from both melanoma and neuronal cells have
been compared and grouped according to their mean/-
normalized quantities (i.e. upregulated or down regu-
lated) or according to their higher or lower frequency of
detection (i.e. # of times each protein is detected in mul-
tiple gel spots). However, no functional significance has
been implied in grouping these proteins (Tables 1, 2,3).
Analyses of known physiological functions for each of the
46 proteins indicated that 44 of 46 proteins (>95%)
expressed in neuronal cells have been shown previously to
be associated with the early stages of brain development,
differentiation and regulation of nervous system. Based
on these biological functions, we have proposed possible
roles of these 46 proteins in signaling antiviral responses,
arrest in tumor cell growth, modulation of cell mem-
branes and in altering the signal transduction pathways
from malignancy to early neurogenesis and cell differenti-
ation (Figure 3).
Antiviral Responses and Arrest in Tumor Growth
The first line of defense against the RD114 virus infection
begins with conformational changes in the melanoma cell
membrane due to binding of the viral envelope glycopro-
teins to its receptor, the NAA transporter protein [4]. The
presence of metalloprotease /aminopeptidase (AMPN) on
the melanoma cell surface can increase heterodimer for-
mation as it cleaves NAAs from the N-terminus of proteins
[7]. The toll-like receptor-4 (Tl-4) recognizes pattern
changes in membrane proteins and triggers the innate
immunity while the antiviral responses are activated by de
novo expression of interferon gamma (ING) in the pres-
ence of tumor necrosis factor (TNF5) and interleukin-1
beta converting enzyme (ICE1) that were already present
in melanoma cells (Fig. 2A&2C). This activates de novo
synthesis of IL-1 receptor beta (IL-1B), IL-2 receptor alpha
chain (IL2A) and IL-6, all of which produce anti-tumori-
genic and inflammatory responses. Co-expression of ING,
IL-6 and other newly synthesized cytokines prompts pro-
teases (AMPN, ICE1 and dipeptidyl peptidase VI (DPP IV/
CD26) to functionally activate these proteins by cleavage
[7]. A series of interactions are then initiated by the acti-
vated IL-1B and IL-6 toward the suppression of metastatic
activity and arrest of melanoma cell growth [8,9]. At this
time, two other proteins CDNA/ p21 and MM07 that are
essential for tumor growth and metastasis respectively are
downregulated and are not detected in trans-differenti-
ated neuronal cells i.e. after the exposure of cat melanoma
Table 3: Lower Detetion Frequency in Neuronal Cells
Protein Name Abbreviation Accession # Functional Category
Beta-glucuronidase precursor BGLR O97524 Lysosomal Enzyme
Cathepsin W precursor CATW Q9TST1 Lysosomal Enzyme
Neurotrophin-3 precursor NT3 Q9TST2 Neurotrophic Favtor
Phosducin PHOS P41686 Cytoplasmic Phosducin
Platelet-derived growth factor, B 
chain precursor
PDGB P12919 Growth Factor
Proto-oncogene tyrosine-protein 
kinase
FES P14238 Tyrosine Kinase (Cytoplasmic/
Transmembrane)
Sarcoplasmic/endoplasmic 
reticulum calcium ATPase 2
ATA2 Q00779 Membrane Calcium Ion Channel 
(Endoplasmic Reticulum)
Serine – pyruvate 
aminotransferase, mitochondrial 
precursor
SPYA P41689 Mitochondrial Enzyme
Tumor necrosis factor ligand 
superfamily member 5
TNF5 O97605 Cytokine
Zona pellucida sperm-binding 
protein 3 precursor
ZP3 P48832 Membrane Receptor
Proteins that were detected at lower frequencies in neuronal cells (also see Fig 2 C)Journal of Translational Medicine 2005, 3:14 http://www.translational-medicine.com/content/3/1/14
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cells to RD114 virus (Fig. 2B). Suppression of these pro-
teins was associated with concurrent expression of P53
tumor suppressor protein as a distinct single protein in
neuronal cells indicating its inhibitory effect on the tumor
growth (Fig 2C *). Thus, the antiviral responses of the
newly induced cytokines and growth regulatory proteins
affect the arrest of tumor cell growth, which then trigger
production of neurotrophic factors that alter the pathways
responsible for modulation of neurogenesis.
Activation of kinases, neuro-regulatory enzymes and 
neurotrophic factors
Both IL-1B and IL-6 are multipotential cytokines capable
of activating kinases necessary for phosphorylation of fac-
tors involved in the transcription of new genes, synthesis
of novel proteins, up-regulation or down-regulation of
many existing proteins that enhance signals for tumor
suppression and neurogenesis. The cytoplasmic kinase of
IL-6 acts synergistically in stimulating production of other
kinases and receptors in a ligand-independent manner
Tentative Signal Transduction Pathways involved in suppression of tumorigenesis and induction of neurogenetic pathways Figure 3
Tentative Signal Transduction Pathways involved in suppression of tumorigenesis and induction of neurogenetic pathways. Pro-
posed protein functions are based on previously published reports.
Neuro-regulatory Enzymes
ACHE; ARSB; BGLR; LIPL; 
NU5M
Neural cell differentiation
Potentiation of Synapses
PIM1; TFRC; PKM2; ITGB1; ZP4
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KFMS; TFRI redistribution;
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IL6 activation of serine-threonine
kinase Pim-1 & concurrent
production of Tyrosine Kinases
KFMS; KIT; FES
Neuroprotection and Survival
OPSR; PHOS; PRIO; FEL2; ALBU;
HEXB
Regulation of Neuronal cell 
Functions and balancing of Cellular
concentrations of 
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ICE1, DPP4 or AMPN enzymes
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Upregulation of p53; ALBU; 
ACES; B2AR; BDNF; ING; 
1IL1B; IL-2A; PIM1: IL6; HEXB; 
KIT; FEL2; LIPL; OPSR; TFR1;
ZP2
Downregulation of ATA2;
CD8B; DCE1; ITB1; FES; 
MMO7; SPYA; NT3; CATW;
CDNA; TNF5; KPYM; ZP3; ZP4
in neuronal cells
De novo expression of
ING & IL-1B 
Activation of ICE1 
Induction of antiviral and growth
inhibitory responses
RD114 envelope binding
to Neutral Amino Acid (NAA) 
transporter protein (receptor):
Inflammatory stimuli & 
cleavage of NAA by AMPNJournal of Translational Medicine 2005, 3:14 http://www.translational-medicine.com/content/3/1/14
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[10]. In addition, the Pim1 serine/ threonine kinase is
expressed as a single non-complexed protein exclusively
in neuronal cells (Fig. 2A *; Table 1 group A). This kinase
phosphorylates proteins in dendritic and nuclear com-
partments of stimulated neurons and it is required for
long-term potentiation of these cells [11]. The red-sensi-
tive opsin receptor (OPSR) that is normally found in reti-
nal rods is expressed de novo in transdifferentiated
neuronal cells after exposure of melanoma cells to the
RD114 virus (Fig. 2A). This integral membrane protein is
phosphorylated on most of its serine and threonine resi-
dues present at its C-terminus [12]. It is possible that pro-
teins that are phosphorylated at the serine or threonine
residues may also be phosphorylated at tyrosine residues
at acidic pH and these may generate distinct neurogenera-
tive pathways [8].
While both melanoma and neuronal cells expressed the
mast/stem cell growth factor receptor tyrosine kinase Kit
(C-Kit), the frequency of detection for this kinase was sig-
nificantly higher in neuronal cells compared to
melanoma (Fig. 2C). Co-expression of c-Kit with IL-6, IL-
2A and IL-B in trans-differentiated cells can further retard
tumor growth while promoting cell signaling, differentia-
tion and potentiation of synapses in conjunction with
other proteins . The membrane tyrosine kinase receptor
(KFMS) for the macrophage colony stimulating factor-1
(CSF-1) was expressed exclusively in neuronal cells and
this protein has been shown to protect neural cells from
degeneration [13,14]. The FES tyrosine protein kinase was
already present in melanoma cells at the time of trans-dif-
ferentiation and this proto-oncogene has been implicated
in morphological differentiation of neuronal cells[15].
The signals produced by IL6 and other cytokines activate
brain-derived neurotrophic factor (BDNF*), a protein
critical for intracellular protein-protein interactions that
result in the development, differentiation, plasticity, and
regeneration of neuronal network in the brain [15]. BDNF
has recently been shown to be critical for neuronal self-
repair following ischemia due to stroke and it contributes
to the functional recovery of neurons [16-18].
BDNF binds to tyrosine kinase receptor with a high affin-
ity [19]. It can also auto-phosphorylate and activate other
signaling molecules. In our model system BDNF was over-
expressed in trans-differentiated cells and it was detected
in gel spots both as a single protein and in the form of
complexes (Table 2: Figure 2C). Concurrent expression of
several kinases, cytokines and growth factors in neuronal
cells appears to have enhanced a network of protein-pro-
tein interactions between different proteins present in the
cell. This is evident by the detection of a large number of
detergent-soluble complexes of proteins in these cells
(Fig. 2A,B&2C).
Analyses of all complexed proteins containing BDNF (Fig.
4A&4B) indicated that 4 of 5 complexes (80%) in neuro-
nal cells and only 1 of 7 complexes (14%) in melanoma
interacted with tyrosine kinase Kit (p= 0.072 based on 2-
sided Fisher's exact test). It is interesting to note that 1 of
the 5 BDNF complexes in neuronal cells that did not con-
tain Kit (not shown in Fig. 4), was found to be associated
with ZP3, PDGB and TL-4 which acts as an adapter-like
protein for BDNF indicating that it was autophosphor-
ylated in the complex without the Kit. This interaction not
only stimulates BDNF activity but together these proteins
increase length of neurites [20,21]. Although the biologi-
cal significance of all the recovered complexes from
melanoma and neuronal cells is not clear yet, our data
suggest that most of the detergent soluble complexes that
we have isolated represent functionally active rather than
randomly aggregated proteins.
Production of BDNF stimulates expression of acetylcho-
linesterase (ACES), an enzyme vital for neurite formation
and transmission of signals in both the sympathetic and
parasympathetic arms of the nervous system [22]. Expres-
sion of ACES in glial cells has been associated with the
induction of prion (PRIO) protein present in most neural
cells [23]. However, since PRIO was already present in
melanoma cells and ACES was expressed only after
RD114 virus infection, it indicates that ACES does not
induce PRIO in these neuronal cells (Fig. 2A&2C). BDNF
also activates beta-2 adrenergic receptor (B2AR) in neuro-
nal cells and promotes protein-protein interactions by
enhanced binding of different kinases, which trigger astro-
gliosis and neuronal cell survival [24].
Both beta-hexosaminidase (HEXB) and lipoprotein lipase
(LIPL) were expressed de novo in trans-differentiated cells
(Fig. 2A). These enzymes not only retard cancer cell
growth but are also critical for synaptic remodeling in the
brain and affect differentiation of neuronal cells respec-
tively [25-27]. The tissue nonspecific isozyme of alkaline
phosphatase (PPBT) was expressed with high frequency.
This neural cell marker binds to prion protein and it
enhances neurotransmission and developmental plastic-
ity [28]. Although PPBT was expressed in both melanoma
and neuronal cells its frequency of detection was signifi-
cantly higher in neuronal cells compared to the tumor
cells (Fig. 2 C). Another important enzyme, arylsulfatase
(ARSB) that desulfates proteins post-translationally and
renders them functional was more frequently expressed in
neuronal cells compared to melanoma. This enzyme is
important for new glial cells and developing neurons in
the brain rather than in mature cells [29].
The pyruvate kinase isoenzyme M1 (KPYM) was downreg-
ulated in trans-differentiated cells but its presence is con-
sidered important for nerve endings [30]. Likewise theJournal of Translational Medicine 2005, 3:14 http://www.translational-medicine.com/content/3/1/14
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down regulation of neurotrophic factor-3 (NT-3) in neu-
ronal cells is noteworthy since this factor is necessary for
the development of mature neurons and enteric nervous
system but it is not essential for the generation of newly
differentiated neural cells [31]. However, presence of NT-
3 has been reported to be essential for enhancement of
invasive potential of these tumor cells [17]. Glutamate
decarboxylase 67 (DCE1) is a key regulatory enzyme for
the neurogenic activity induced by neurotrophic factors
[32] and the polycomb complex protein BMI1 is required
for stem cell renewal [33] together with Kit, PDGB, NT-3,
BDNF and others.
One of the most frequently detected cell membrane pro-
teins, in both melanoma and neuronal cells was integrin
VLA-4 beta I subunit (ITB/ CD29). This protein was
present in both single and complex forms in both cell
types (Fig. 2C). Integrins are cell-surface receptors with
multifunctional domains that bind to numerous ligands
and transduce signals through a cascade of intracellular
events that help in the development of laminae in the cen-
tral nervous system [34]. In particular, Kit and beta-1
integrins collaborate in modulating cellular functions
[35]. During neurogenesis, the synthesis and mobility of
integrin is increased by the presence of both BDNF and
PDGB [36,37]. These proteins also redistribute transferrin
(TFR1) to the membranes of immature neurons, a process
essential for neurite formation, axonal cell growth and for
regulation of IL-1B production [38,39].
The sarcoplasmic/endoplasmic reticulum calcium ATPase
2 (ATA2) enzyme was detected with a high frequency in
both melanoma and neuronal cells and sodium/calcium
exchanger 1 (NAC1) a plasma membrane pump was
expressed at a slightly higher frequency in neuronal cells
than in melanoma (Fig. 2C). Both proteins are essential
for neural development, regulation of intracellular con-
centration of calcium and maintenance of plasticity and
synapses, [40].
Expression of different isomers of zona pellucida (ZP2,
ZP3 and ZP4) in both melanoma and neuronal cells was
totally unanticipated. Although exact function of these
sperm-binding receptor proteins in melanoma or neuro-
nal cells is not known, recent reports suggest that ZP
domains particularly those of ZP2 that is upregulated in
neuronal cells may transduce intracellular signals neces-
sary for polymerization of proteins into neural filaments
required for mechano-sensory dendrites [41,42]. It is also
possible that ZP proteins may participate in the formation
of multipolar extensions in trans-differentiated cells dur-
ing early neurogenesis. Phosducin (PHOS) is an abundant
sensory protein and opsin, is a red-sensitive protein
expressed in retinal rods, synapses and photoreceptor cells
[43]. Expression of both of these neuro-sensory proteins
may be involved in transduction of neurogenic signal in
trans-differentiated cells.
Conclusion
We have shown that RD114 virus infection of cat
melanoma cells induces a repertoire of novel proteins that
Protein complexes as identified by mass spectrometry in sin- gle spots Figure 4
Protein complexes as identified by mass spectrometry in sin-
gle spots. All proteins identified in one complex are drawn by 
a single color. A represents 4 of the 5 complexes found in 
trans-differentiated neuronal cells. Each complex contains 
brain-derived neurotrophic factor (BDNF*) and its interact-
ing partner proteins. Each color in the diagram represents 
one complex of BDNF with other interacting proteins as 
identified by mass spectrometry. NOTE that all BDNF-
interactive proteins in the 4 complexes in neuronal cells con-
tain Kit tyrosine kinase. B displays proteins in 5 complexes 
derived from melanoma cells. NOTE that only one complex 
in melanoma cells contains Kit with no other protein in this 
complex.
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suppress its tumorigenic potential and promote neuronal
cell differentiation in vitro. To our knowledge, this is the
first demonstration that epigenetic stimuli from the cell
surface of a naturally occurring melanoma can generate
neurogenetic signals that can alter the genome-wide tran-
scriptional and translational programs such that its onco-
genic pathways are halted and pro-neuronal auto-
regulatory mechanisms are prompted toward neural cell
differentiation.
By immunohistochemistry numerous markers of neural
cell neoplasms (S-100 protein, neurofilament, epithelial
membrane antigen, Leu-7 (CD57), neural specific eno-
lase, neuro-peptide substance P, the low-affinity nerve
growth factor receptor (p75NGFR), neural cell adhesion
molecule (CD56/N-CAM) and growth-associated phos-
phoprotein-43) have been shown to enhance malignant
potential of melanomas and neuronal cell-derived tumors
[44-46]. In addition, peripherin, an intermediate filament
protein is expressed during the transition of a neuronal
cell to a Schwann cell phenotype and during the normal
maturation of epithelioid melanocytes or melanocytic
nevi [47]. Based on the immunohistochemical staining,
many different tumor types such as neurotropic or desmo-
plastic melanomas, neuroepithelial and malignant granu-
lar cell tumors have also been grouped together as
malignant peripheral nerve sheath tumors [48]. None of
these proteins was detected in the melanoma or trans-dif-
ferentiated neuronal cells that we have studied. This could
be because we have primarily focused on proteins and
profiles (upregulated, down regulated or de novo
expressed) that distinguish highly malignant melanoma
cells from their counterpart trans-differentiated neuronal
cells. Our proteomics studies also emphasize that
although a significant number of the expressed proteins
are shared between the two cell types, distinct protein-
protein interactions are operative in altering signals that
lead cells toward tumorigenic or neurogenic pathways.
Expression of >69% of germ-line associated sensory or
neurogenic signaling proteins, neural-specific enzymes,
cytokines, neurotrophic/ growth factors, serine, threonine
and tyrosine kinases in cat melanoma cells as well as in
trans-differentiated counterpart cells, supports the stem
cell origin of this tumor and suggests that the precursor of
this melanoma is a stem-like cell rather than the primitive
melanoblast committed to melanocytic differentiation
only. These cells are unique in that they are fully differen-
tiated (pigmented) and they have the ability to give rise to
new cell types that express differentiation-specific pro-
teins. In addition, these cells express many proteins
involved in self-renewal of cells. These include the stem
cell growth factor receptor protein (C-Kit), PDGB, BDNF,
NT-3, polycomb protein 1 and others. Recently, BMI1 has
been shown to be essential for efficient self-renewal of
neural stem cells [33,49]. As can be seen in Fig 2C, BMI 1
and other protein involved in self-renewal are expressed
both in melanoma and trans-differentiated neuronal cells
but these are upregulated in neuronal cells. Since both
melanocytes and neuronal cells arise from the neural crest
of the embryo our studies indicate that CT1413
melanoma is a stem cell tumor.
Based on our findings it can also be speculated that a high
incidence of cutaneous melanomas and atypical
melanocytic nevi in patients with hereditary neurofi-
broma, astrocytoma, glioma, meningioma, and other
neuronal tumors [50], may also arise due to the expres-
sion or suppression of specific embryonic stem cell pro-
teins in these cells. Correlation of cellular phenotypes
with signature patterns of proteins in response to epige-
netic or environmental changes would now be critical in
establishing molecular definitions for classifying clini-
cally related tumors.
To gain a better insight into the complex processes of
oncogenesis or neurogenesis, it would also be important
to identify proteins in various natural biological settings
since most substrate proteins are cleaved by proteases
prior to enzyme interactions. Defining the specificity of
natural targets may throw light on how biological specifi-
cities are achieved in nature. This model system offers a
unique opportunity to study protein profiles in relation to
specific ligand-binding interactions that are capable of
inducing genetic or phenotypic changes in these cells.
Characterization of protein-protein interaction domains
by the use of constitutively active and dominantly nega-
tive constructs and screening of small peptides or interfer-
ing RNAs would provide new knowledge into functional
significance of each of the proteins that direct cells toward
distinct pathways (i.e. oncogenic versus neurogenic).
These studies would also have important clinical implica-
tions for understanding neurogenerative and neuropro-
tective mechanisms for neurologic disorders since
activated proteins may induce changes in protein subunits
in a cell-type specific manner. This information would
help in identifying selective inhibitors for tumors and
activators/co-activators of neurogenic proteins involved
in neural cell development.
Materials and Methods
Cell Cultures
A cat melanoma cell line (CT1413) was established in vitro
from a highly metastatic and melanotic tumor of the lung
[2]. Cells were grown in minimal essential medium
(MEM) with 10% fetal bovine serum and 2 mM glutamine
(growth medium) and were plated in 36 flasks (75 cm2),
at a density of 2 × 106 cells/ flask in medium containing 2-
ug/ml polybrene [2]. After 24 hrs, culture medium was
removed and fresh growth medium containing RD114Journal of Translational Medicine 2005, 3:14 http://www.translational-medicine.com/content/3/1/14
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virus was added. RD114 is an endogenous retrovirus orig-
inally derived from the brain of a young cat and grown in
human rhabdomyosarcoma cells [51]. This virus repli-
cates in a wide range of different mammalian cells and
does not induce any pathology in healthy cats or in cul-
tures derived from cat embryo cells in vitro [52]. The
RD114 virus was added to 12 flasks with a multiplicity of
infection (MOI) of 1 and another set of 12 cultures was
exposed to MOI of 0.25. An additional set of 12 flasks of
melanoma cells was cultured without the virus as unin-
fected controls. After 48 hours post-virus infections, cul-
tures exposed to MOI of 1 showed neuronal cell
morphology and this experiment was highly reproducible
[3].
To validate protein profiles two independent cell culture
experiments were conducted almost 12 months apart and
proteomes of both cell types were analyzed separately for
differential expression profiles.
Proteomics Studies
Proteins were extracted from 12 flasks each of the trans-
differentiated and counterpart melanoma cells from each
of the two experiments. Cells were washed 3× with phos-
phate buffered saline (PBS) to remove serum and other
proteins, and 2 × 107 cells from each set of experimental
and control melanoma cells were removed by the use of a
cell-scraper or a "rubber policeman" (i.e. not treated with
trypsin to detach cells). Each cell pellet was washed again
2× with PBS and proteins were extracted sequentially by a
modified two-step solubilization procedure using two
reagents containing different concentrations of 5–8 M
Urea, 2%–4% CHAPS, 2 M thiourea and other non-ionic
and/zwitterionic detergents (BioRad Sequential extraction
kit CA, USA). The most soluble membrane proteins were
removed in the first extraction and the less soluble
proteins were separated in the second fraction. In order to
isolate proteins as close to their natural states in cells as
possible, each solubilization step was modified by rapid
lysis technique (only 10–15 seconds' cell lysis with 2-sec-
onds' sonication) followed by centrifugation for 90 min-
utes at 100,000 × g prior to analyzing soluble proteins
present in the supernatant by isoelectric focusing (IEF).
All protein fractions from melanoma controls and trans-
differentiated neuronal cells were analyzed separately by
2-dimensional gel electrophoresis (2DGE). In the first
dimension proteins were separated by IEF on a pH gradi-
ent 3–10 and then size fractionated in the second dimen-
sion on 6–18% gradient of SDS-polyacrylamide gels.
Proteins were stained with Coomassie blue and by the use
of a CCD camera and an image-processing analytical pro-
gram (PDQuest from BioRad) all protein spots were eval-
uated from each of the 15 gels (9 gels from the first
experiment and 6 gels from the second experiments). This
program compares both the quality and normalized
quantity of each spot across 15 gels and creates a master
gel-image of well-calibrated and quantifiable spots using
internal reference proteins. A master gel containing 3,129
spots was used to compare each of the corresponding
spots in all gels derived from melanoma controls and
trans-differentiated neuronal cell. All differentially
expressed (i.e. upregulated and down-regulated) proteins
were identified in each gel and 467 spots including some
spots common to both cell types were excised from mul-
tiple gels. Proteins were digested using ultra-pure trypsin
and peptide fingerprints of each in-gel digest were
analyzed by MALDI-TOF-MS. Full scan mass spectra were
acquired and high mass accuracy criteria were used
throughout the study with high resolution and strict
trypsin specificity. Spectra were submitted to the Protein
database (SWISS-PROT) for searching protein
identification. In addition to using these stringent criteria,
we used manual acquisitions of spectra, which yielded
more reliable and reproducible results compared to auto-
mated acquisitions using PS1 software. The confidence
level in our protein identification was high because
almost all proteins were confirmed in corresponding
spots in multiple gels and by duplicating the entire
experiment for validation. In this study we included only
those proteins that were most reproducible in the high
stringency Feline Protein database and results were con-
firmed in other mammalian species (SWISS-PROT). Thus
far we have identified 46 proteins among 302 spots from
multiple gels tested. All spots in which proteins were not
identified reproducibly by mass spectrometry from the
same or different gels were NOT included in any analysis.
Statistical Analyses
The frequency distribution between melanoma and neu-
ronal cells was compared using Chi-square test or 2-sided
Fisher's exact test. The mean quantity for each protein was
compared between melanoma and neuronal cells using
the Mann-Whitney rank-sum test and the probability of a
protein occurrence in the trans-differentiated neuronal
versus melanoma cells was examined based on the bino-
mial probability distribution with an expected proportion
less than 0.05.
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